Patient-reported experiences with side effects of kidney cancer therapies and corresponding information flow
Abstract Background Treatment options for metastatic renal cell carcinoma (mRCC) have improved over recent years. Various therapies for metastatic renal cell carcinoma are currently approved for first and successive lines. Having various treatment options makes it important to reflect how patients e...
Main Authors: | Karin Kastrati, Viktoria Mathies, Anna P. Kipp, Jutta Huebner |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-12-01
|
Series: | Journal of Patient-Reported Outcomes |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41687-022-00533-z |
Similar Items
-
Kidney Transplantation Improves Health-Related Quality of Life in Older Recipients
by: Silke E. de Boer, et al.
Published: (2024-04-01) -
Uncommon Side Effects of Sunitinib Therapy in a Patient with Metastatic Renal Cell Cancer: Case Report
by: Robert Šeparović, et al.
Published: (2018-01-01) -
Identifying Patient-Reported Outcome Measures (PROMs) for Routine Surveillance of Physical and Emotional Symptoms in Head and Neck Cancer Populations: A Systematic Review
by: Sheilla de Oliveira Faria, et al.
Published: (2021-09-01) -
Laparoscopic retroperitoneal heminephrectomy for renal cell carcinoma in horseshoe kidney: a case report and review of the literature
by: Xuan Thai Ngo, et al.
Published: (2023-12-01) -
Renal cell carcinoma in autosomal dominant polycystic kidney disease: A case report
by: Gullyawan Rooseno, et al.
Published: (2023-12-01)